Top News Stories
News
FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers
By Alan GoforthThe agency has stepped up its campaign against drugmakers' improper listing of patents in the FDA's Orange Book, which it contends are ploys intended to delay generic competition, by disputing junk patent listings for 300 drugs.










